Protein kinase R and the integrated stress response drive immunopathology caused by mutations in the RNA deaminase ADAR1.

[1]  T. Shibuya,et al.  Disruption of Z-RNA–binding of ADAR1 induces Aicardi-Goutières syndrome–like encephalopathy in mice , 2020, bioRxiv.

[2]  J. Rehwinkel,et al.  Recognition of Z-RNA by ADAR1 limits interferon responses , 2020, bioRxiv.

[3]  B. Lambrecht,et al.  ADAR1 interaction with Z-RNA promotes editing of endogenous double-stranded RNA and prevents MDA5-dependent immune activation , 2020, bioRxiv.

[4]  Y. Harada,et al.  Viral RNA recognition by LGP2 and MDA5, and activation of signaling through step-by-step conformational changes , 2020, Nucleic acids research.

[5]  R. Silverman,et al.  A phenolic small molecule inhibitor of RNase L prevents cell death from ADAR1 deficiency , 2020, Proceedings of the National Academy of Sciences.

[6]  P. Walter,et al.  The integrated stress response: From mechanism to disease , 2020, Science.

[7]  Gennady Korotkevich,et al.  Fast gene set enrichment analysis , 2019, bioRxiv.

[8]  J. Doench,et al.  Loss of ADAR1 in tumours overcomes resistance to immune checkpoint blockade , 2018, Nature.

[9]  Ashton C. Berger,et al.  Author Correction: Identification of ADAR1 adenosine deaminase dependency in a subset of cancer cells , 2018, Nature Communications.

[10]  Nimrod D. Rubinstein,et al.  eIF2B activator prevents neurological defects caused by a chronic integrated stress response , 2018, bioRxiv.

[11]  L. Parts,et al.  Binding of ISRIB reveals a regulatory site in the nucleotide exchange factor eIF2B , 2018, Science.

[12]  C. Rice,et al.  Human ADAR1 Prevents Endogenous RNA from Triggering Translational Shutdown , 2018, Cell.

[13]  Cheng-Zhong Zhang,et al.  Breaching Self-Tolerance to Alu Duplex RNA Underlies MDA5-Mediated Inflammation , 2018, Cell.

[14]  A. Renslo,et al.  Structure of the nucleotide exchange factor eIF2B reveals mechanism of memory-enhancing molecule , 2017, Science.

[15]  D. Liggitt,et al.  The A946T variant IFIH1 RNA sensor mediates an interferon program that limits viral infection but increases the risk for autoimmunity , 2017, Nature Immunology.

[16]  Elizabeth E Gray,et al.  Intracellular Nucleic Acid Detection in Autoimmunity. , 2017, Annual review of immunology.

[17]  R. Silverman,et al.  Ribonuclease L mediates the cell-lethal phenotype of double-stranded RNA editing enzyme ADAR1 deficiency in a human cell line , 2017, eLife.

[18]  Elizabeth E Gray,et al.  The AIM2-like Receptors Are Dispensable for the Interferon Response to Intracellular DNA. , 2016, Immunity.

[19]  D. Levy,et al.  PKR Transduces MDA5-Dependent Signals for Type I IFN Induction , 2016, PLoS pathogens.

[20]  B. Popko,et al.  Harnessing the integrated stress response for the treatment of multiple sclerosis , 2016, The Lancet Neurology.

[21]  R. Flavell,et al.  Generation of Genetically Modified Mice Using the CRISPR-Cas9 Genome-Editing System. , 2016, Cold Spring Harbor protocols.

[22]  C. Samuel,et al.  Editing of Cellular Self-RNAs by Adenosine Deaminase ADAR1 Suppresses Innate Immune Stress Responses* , 2016, The Journal of Biological Chemistry.

[23]  Cory C. Funk,et al.  Isoforms of RNA-Editing Enzyme ADAR1 Independently Control Nucleic Acid Sensor MDA5-Driven Autoimmunity and Multi-organ Development. , 2015, Immunity.

[24]  Zhijian J. Chen,et al.  Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases , 2015, Proceedings of the National Academy of Sciences.

[25]  P. Seeburg,et al.  RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself , 2015, Science.

[26]  Elizabeth E Gray,et al.  Cutting Edge: cGAS Is Required for Lethal Autoimmune Disease in the Trex1-Deficient Mouse Model of Aicardi–Goutières Syndrome , 2015, The Journal of Immunology.

[27]  P. Fischer,et al.  Mutations in a translation initiation factor identify the target of a memory-enhancing compound , 2015, Science.

[28]  S. Gygi,et al.  A critical role for PKR complexes with TRBP in Immunometabolic regulation and eIF2α phosphorylation in obesity. , 2015, Cell reports.

[29]  L. Lagae,et al.  Characterization of human disease phenotypes associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, ADAR, and IFIH1 , 2015, American journal of medical genetics. Part A.

[30]  Anna M. McGeachy,et al.  The small molecule ISRIB reverses the effects of eIF2α phosphorylation on translation and stress granule assembly , 2015, eLife.

[31]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[32]  Chris P. Ponting,et al.  The RNA-Editing Enzyme ADAR1 Controls Innate Immune Responses to RNA , 2014, Cell reports.

[33]  B. van Steensel,et al.  Easy quantitative assessment of genome editing by sequence trace decomposition , 2014, Nucleic acids research.

[34]  R. Lamb,et al.  The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly. , 2014, Molecular cell.

[35]  V. Hornung,et al.  OAS proteins and cGAS: unifying concepts in sensing and responding to cytosolic nucleic acids , 2014, Nature Reviews Immunology.

[36]  Sharmin Begum,et al.  Identification of an LGP2-associated MDA5 agonist in picornavirus-infected cells , 2013, eLife.

[37]  A. Vanderver,et al.  Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study , 2013, The Lancet Neurology.

[38]  A. Munnich,et al.  A type I interferon signature identifies bilateral striatal necrosis due to mutations in ADAR1 , 2013, Journal of Medical Genetics.

[39]  V. Hornung,et al.  Structural mechanism of cytosolic DNA sensing by cGAS , 2013, Nature.

[40]  K. Nader,et al.  Pharmacological brake-release of mRNA translation enhances cognitive memory , 2013, eLife.

[41]  C. Reis e Sousa,et al.  Cytosolic Sensing of Viruses , 2013, Immunity.

[42]  Tamio Suzuki,et al.  Dyschromatosis symmetrica hereditaria , 2013, The Journal of dermatology.

[43]  Jon R Lorsch,et al.  The mechanism of eukaryotic translation initiation: new insights and challenges. , 2012, Cold Spring Harbor perspectives in biology.

[44]  John H Livingston,et al.  Mutations in ADAR1 cause Aicardi-Goutières syndrome associated with a type I interferon signature , 2012, Nature Genetics.

[45]  M. Diamond,et al.  The RIG-I-like receptor LGP2 controls CD8(+) T cell survival and fitness. , 2012, Immunity.

[46]  D. Stetson,et al.  Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. , 2012, Immunity.

[47]  M. Jolly,et al.  Autoimmune Disease Risk Variant of IFIH1 Is Associated with Increased Sensitivity to IFN-α and Serologic Autoimmunity in Lupus Patients , 2011, The Journal of Immunology.

[48]  P. Desprès,et al.  The oligoadenylate synthetase family: an ancient protein family with multiple antiviral activities. , 2011, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[49]  C. Samuel,et al.  RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis , 2010, Proceedings of the National Academy of Sciences.

[50]  J. Itskovitz‐Eldor,et al.  Alu Sequences in Undifferentiated Human Embryonic Stem Cells Display High Levels of A-to-I RNA Editing , 2010, PloS one.

[51]  S. Akira,et al.  Protein kinase R contributes to immunity against specific viruses by regulating interferon mRNA integrity. , 2010, Cell host & microbe.

[52]  C. Samuel,et al.  RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment. , 2010, Virology.

[53]  S. Akira,et al.  LGP2 is a positive regulator of RIG-I– and MDA5-mediated antiviral responses , 2010, Proceedings of the National Academy of Sciences.

[54]  J. Todd,et al.  Rare Variants of IFIH1, a Gene Implicated in Antiviral Responses, Protect Against Type 1 Diabetes , 2009, Science.

[55]  S. Orkin,et al.  ADAR1 is essential for maintenance of hematopoiesis and suppression of interferon signaling , 2008, Nature Immunology.

[56]  Nels C. Elde,et al.  Protein kinase R reveals an evolutionary model for defeating viral mimicry , 2008, Nature.

[57]  T. Heidmann,et al.  Trex1 Prevents Cell-Intrinsic Initiation of Autoimmunity , 2008, Cell.

[58]  T. Maniatis,et al.  Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity , 2007, Science.

[59]  Richard A Flavell,et al.  Essential role of mda-5 in type I IFN responses to polyriboinosinic:polyribocytidylic acid and encephalomyocarditis picornavirus. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[60]  J. Sprent,et al.  Type I interferons act directly on CD8 T cells to allow clonal expansion and memory formation in response to viral infection , 2005, The Journal of experimental medicine.

[61]  P. Seeburg,et al.  Liver Disintegration in the Mouse Embryo Caused by Deficiency in the RNA-editing Enzyme ADAR1* , 2004, Journal of Biological Chemistry.

[62]  M. Weiss,et al.  Stress-induced Apoptosis Associated with Null Mutation of ADAR1 RNA Editing Deaminase Gene* , 2004, Journal of Biological Chemistry.

[63]  R. Paules,et al.  An integrated stress response regulates amino acid metabolism and resistance to oxidative stress. , 2003, Molecular cell.

[64]  S. Naidu,et al.  Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter , 2002, Annals of neurology.

[65]  Rune R. Frants,et al.  Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter , 2001, Nature Genetics.

[66]  A. Hinnebusch,et al.  Tight Binding of the Phosphorylated α Subunit of Initiation Factor 2 (eIF2α) to the Regulatory Subunits of Guanine Nucleotide Exchange Factor eIF2B Is Required for Inhibition of Translation Initiation , 2001, Molecular and Cellular Biology.

[67]  M. Schapira,et al.  Regulated translation initiation controls stress-induced gene expression in mammalian cells. , 2000, Molecular cell.

[68]  H. Atkins,et al.  Characterization of Transgenic Mice with Targeted Disruption of the Catalytic Domain of the Double-stranded RNA-dependent Protein Kinase, PKR* , 1999, The Journal of Biological Chemistry.

[69]  R. Silverman,et al.  Interferon action and apoptosis are defective in mice devoid of 2′,5′‐oligoadenylate‐dependent RNase L , 1997, The EMBO journal.

[70]  M. Hentze,et al.  Starting at the Beginning, Middle, and End: Translation Initiation in Eukaryotes , 1997, Cell.

[71]  C. Samuel,et al.  Expression and regulation by interferon of a double-stranded-RNA-specific adenosine deaminase from human cells: evidence for two forms of the deaminase , 1995, Molecular and cellular biology.

[72]  M Aguet,et al.  Functional role of type I and type II interferons in antiviral defense. , 1994, Science.

[73]  Robert H. Silverman,et al.  Expression cloning of 2-5A-dependent RNAase: A uniquely regulated mediator of interferon action , 1993, Cell.

[74]  P. Seeburg,et al.  Modulation of microRNA processing and expression through RNA editing by ADAR deaminases , 2006, Nature Structural &Molecular Biology.